Lipo‐Glc‐1,6‐ <scp> P <sub>2</sub> </scp> : A Bioprecursor Prodrug for Phosphomannomutase‐2 Congenital Disorder of Glycosylation
Federica Sodano(Federico II University Hospital), Giuseppina Andreotti(National Research Council)
Cited by 0
Related Papers
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
|PLoS ONE|2015|32
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease
|International Journal of Molecular Sciences|2023|15